Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00652873
- Locations
- 🇨🇦
Anapharm, Inc., Sainte-Foy, Quebec, Canada
Bioavailability Study of Leflunomide Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT00653003
Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00652821
Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT00653315
Bioavailability Study of Leflunomide Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT00652665
Bioavailability Study of Propranolol Under Fasting Conditions
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00653120
- Locations
- 🇨🇦
SFBC Anapharm, Sainte- Foy, Quebec, Canada
Bioavailability Study of Clonazepam Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00652639
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00653380
- Locations
- 🇨🇦
Anapharm, Inc., Sainte-Foy, Quebec, Canada
Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00652795
- Locations
- 🇨🇦
Anapharm, Sainte-Foy, Quebec, Canada
Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Par Pharmaceutical, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT00653393
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc, Ft. Myers, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath